502.495.5040

Sur-prise, Sur-prise, Sur-prise

Jun
29

Who remembers Gomer Pyle being awestruck by some of life’s simplest things? Many times he would exclaim, “Gawwwleee,” “Shazam,” and of course “Sur-prise, sur-prise, sur-prise!” I started to have a similar reaction reading a recent study published in the Journal of the American Medical Association and summarized in a Washington Post article by Carolyn Johnson.

 

There was a survey of over 26,000 adults that examined polypharmacy and the results of utilizing prescription medications that have depression listed as a possible reaction. Guess what… survey says… using prescriptions “that have depression as a potential adverse effect was common and associated with greater likelihood of concurrent depression.”

 

Although the conclusions seem self-evident, this study is just part of lots of research that is closely examining polypharmacy and its impact on patients. Dr. Dima Qato, an assistant professor at the University of Illinois, who led the study, is concerned about the little attention being paid to the role of medications and depression. Her quote is right on the money: “We know polypharmacy is growing, we know it is not always promoting good health and longevity in patients, and we know a lot of drugs have certain adverse effects — and one of them is depression.”

 

Surprised? I’m not.

 

Ignore polypharmacy at your own risk. Don’t be surprised.

 

Call us. We can do better.

William Faris, JD
Chief Executive Officer
502-495-5040
william.faris@omca.biz
www.omca.biz

Posted in OMCA, Workers’ Compensation